Mark Samuels - Life Science Access Academy

View Mark Samuels's Profile

Mark has been the CEO of the British Generic Manufacturers Association (BGMA) since December 2020, representing the industry that supplies four out of five medicines to the NHS. With over 15 years of experience in executive and board-level roles across the life sciences sector – spanning government, academia, and the private sector – he brings a wealth of knowledge, expertise, and vision to this position. He is also a member of the Government’s Life Sciences Council, advising on the strategic direction and priorities for the UK’s Life Sciences Industry.

Mark has a proven CEO and Managing Director track record, including leading complex collaborations, national infrastructure projects and international trade deals. He is well-versed in securing funding, investment, and partnerships for large-scale research and development projects involving multiple stakeholders. Some of his achievements include co-founding the Medicines Discovery Catapult, securing a $21m R&D investment from Teva Pharmaceuticals, co-chairing the transformation programme for NICE’s evaluation of medical technologies, and chairing the board that established the UK Stem Cell Transplant clinical trials partnership. He also holds a PGDip in Organisational Leadership from the University of Oxford and is a former Policy Fellow at the University of Cambridge.

Mark Samuels

Previous Masterclasses

Generics, Branded Generics and Biosimilars: NHS Update

Fri 2nd Feb 2024 13:00 – 14:00 GMT

What people say

Marsha Gray, Training Specialist

Boehringer Ingelheim Ltd

“Working with Life Science Access Academy, our company love the variety of the many courses that are on offer. The hour long courses on specific subjects are really useful on Friday lunchtimes for our field teams and gain a lot of interest.

Life Science Access Academy are also super flexible and helpful when it comes to tailoring some additional sessions to our needs.”

Paul Runeckles, Director of Execution Excellence

Ferring

“We have been partnered with LSAA for several years now which has enabled our team members to develop their competencies and capabilities.

With over 700 learning modules, regular webinars on highly relevant topics across the UK, the opportunity to engage with expert speakers after events and regular blogs and newsletters, the platform is a highly valued resource at Ferring.

The team also provides regular usage statistics so we can understand the hot topics in Ferring and enable colleagues to share knowledge and experience with each other.”

Simon Warden, National Sales Manager

Frontier Medical Group

“Frontier Medical has fully implemented, Life Science Access Academy allowing Sales and Marketing to utilise the system. Maximising on line learning for all remote staff stimulates a culture of self-development giving individuals the accountability and responsibility to broaden their skills set.

Life Science Access Academy training is topical and a good fit for the faced paced healthcare market.”

Richard Edmonds

Gedeon Richter Women's Health

“I have found the training via the Life Science Access Academy to be excellent and I know many of my colleagues have as well.

The content is always kept up to date and there is huge and interesting variety of topics covered. The site is curated in a way that makes it clear and easy to navigate. Also, the staff at Life Science access Academy are friendly and responsive and all the experts are always knowledgeable in their areas.”

Robb Sayers, UK Capability Lead

ViiV Healthcare

“The variety and relevancy of content brings value to many different roles across the healthcare industry.

I have also been overwhelmed by the way the Life Science Access Academy team have accommodated our own business needs, being sensitive yet responsive to helping us since its formation.”